David Coti

About David Coti

David Coti is a French executive and investor best known for his role as a CARMAT board member, a position to which he was proposed in 2021 as the company entered a new strategic phase focused on industrialization and commercialization of its Aeson® total artificial heart. At CARMAT, he does not hold an operational management role; rather, he contributes at board level through strategic oversight and governance support. His appointment reflected the company’s desire to strengthen its board with experience in international business development, investment, and high-growth innovation environments. Coti holds a dual degree in international business, including studies at ESSEC International and Plekhanov University in Moscow. He began his career in the 2000s by founding a distribution company in the Commonwealth of Independent States, which gave him early exposure to cross-border business development and emerging markets. He later shifted toward investment and family office management, building a profile centered on sectors such as life sciences, biotechnology, and cleantech. Since 2015, he has managed various family office activities, including those linked to the Gaspard family, owners of the Lyreco group. In parallel, he has taken on operational and governance responsibilities beyond investment. Since 2016, he has served as Vice President, Marketing at TBR, a digital marketing company, and he is also a member of the governance committee of Investir &+, an investment platform supporting entrepreneurs with strong social or environmental impact. This mix of entrepreneurial, financial, and governance experience is particularly relevant in a company like CARMAT, where innovation, regulation, industrial execution, and market access must be aligned. His profile suggests a board-level contribution focused on strategic discipline, growth perspectives, and the scaling of complex technology-driven businesses.